Antimicrobial Agents Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, UK. aeron.hurt@infl uenzacentre.org
Lancet Infect Dis. 2012 Mar;12(3):249-53. doi: 10.1016/S1473-3099(11)70316-4. Epub 2011 Nov 17.
Antibiotic use not only underpins modern medicine, but has brought huge changes to the world, especially in expectations of survival of children into adulthood. The theme of World Health Day, 2011, was "antimicrobial resistance: no action today and no cure tomorrow". The demise of antibacterial drug discovery brings the spectre of untreatable infections. To prevent this crisis immediate action is needed and a new initiative, Antibiotic Action, has been launched. By bringing together communities who need these drugs with academia, health-care professionals, and pharmaceutical companies, this initiative aims to strengthen and enhance academic-industrial partnerships, bring about revision of costly and laborious processes of licensing and regulation of new antibiotics, and address the economics of antimicrobial drugs (cost of use vs profit). A global alliance for antibiotic drug discovery and development would provide a platform for these initiatives.
抗生素的使用不仅是现代医学的基础,而且给世界带来了巨大的变化,尤其是在儿童成年后的生存预期方面。2011 年世界卫生日的主题是“抵御抗菌素耐药性:今天不采取行动,明天就无药可用”。抗菌药物研发的失败带来了无法治疗的感染的威胁。为了防止这场危机,需要立即采取行动,并且已经发起了一项新的倡议,即“抗生素行动”。通过将需要这些药物的社区与学术界、医疗保健专业人员和制药公司聚集在一起,该倡议旨在加强和增强学术-工业伙伴关系,修订新抗生素的许可和监管的昂贵和繁琐的流程,并解决抗菌药物的经济学问题(使用成本与利润)。一个全球抗生素药物发现和开发联盟将为这些倡议提供一个平台。